Bifidobacterium lactis and Reduced Abnormal Colonic Lesions

• Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions.

  • 2025-03-21
  • Applied microbiology and biotechnology 109(1)
  • • Yi-Lin Chan
    • Jun-Cheng Liao
    • Tsung-Lin Li
    • Chang-Jer Wu
    • Yi-Han Chiu

  • PubMed: 40116950
  • DOI: 10.1007/s00253-025-13445-x

  5 Insights on

  • Reduced Abnormal Colonic Lesions

  • Low evidence
  • Animal Study

  both B. lactis P and B. lactis S could attenuate AOM/DSS-induced body weight loss and intestine damage, reduce aberrant crypt foci (ACF) and the formation of colonic polyps

  Effect

  Beneficial

  Effect size

  Large